As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...